Overall, more research is needed to fully understand ALCARs influence on cardiovascular health
Even if GLP-1 medications are inaccessible due to cost there are other medications that might help, and we can discuss risks and benefits of these. So if menopausal weight gain is on your mind, and the chatter about semaglutide and other GLP-1 medications has you curious, please dont be shy
The study, which has not yet been peer-reviewed, had some limitations, according to the researchers
The glucagon component in Retatrutide appears to do something metabolically distinct beyond that, and the clinical data reflects it
Obesity is a chronic condition, and patients may benefit from taking GLP-1s long term, especially if they also have conditions such as diabetes, cardiovascular disease, obstructive sleep apnea, or metabolic dysfunction-associated steatohepatitis (MASH)
Strayer D, Scott V, Carter W